Achieve Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2019

The following table summarizes our contractual obligations as of September 30, 2019 (in thousands):

	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years
Vancouver office operating lease	$	214	$	16	$	128	$	70	$	—
Seattle office operating lease	$	209	$	36	$	173	$	—	$	—
Total	$	423	$	52	$	301	$	70	$	—

Other information related to leases was as follows:

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2019			2018		2019			2018
Supplemental Cash Flows Information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	42		$	—	$	133		$	—
Right-of-use assets obtained in exchange for lease obligations:
Operating leases		—			—	$	455			—
Weighted Average Remaining Lease Term
Operating leases	2.36 years				—	2.36 years				—
Weighted Average Discount Rate
Operating leases		9.97	%		—		9.97	%		—

Future minimum lease payments under the Vancouver lease are as follows (in thousands):

The future minimum annual lease payments under the Seattle Lease are as follows (in thousands):